|
|---|
...designing, developing and manufacturing innovative platelet technologies that have revolutionized Platelet Function testing in Clinical and Research Laboratories. Providing the most comprehensive platelet tests available from any one company, CHRONO-LOG® Platelet Aggregation and Secretion methodologies have been reliable tools in the diagnosis of platelet function defects, monitoring of anti-platelet drugs and assisting researchers in developing novel therapies.
Identify risk of bleeding or
thrombosis and select patients
for anti-platelet drug therapy
Improve patient care and reduce health care costs
○ Transfusion costs
○ Surgical delays
○ Extended hospital stays
Anti-platelet drug therapy
○ Detect patients at risk of thrombosis
○ Monitor for compliance and effectiveness
○ Optimize drug therapies
**
Improve patient care
Diagnose specific platelet disorders such as Von Willebrand Disease, Glanzmann's Thrombasthenia, Storage Pool Disease and Secretion Defects
Comprehensive Platelet Testing Methodologies
Whole Blood / Impedance Aggregation
- Quickly screen platelet function in the more physiologic Whole Blood environment
- Eliminate need for excessive blood draw and save time on sample preparation
- Detect Hyper-aggregability [thrombotic risk]
- Improve detection of drugs, food items and herbs providing anti-platelet properties
Optical/LTA Aggregation
- Improved sensitivity with the twin-well, dual beam detection system
- Reduce down time with NO-Cost Optical Calibration performed by Lab Personnel
- Test with PRP, Washed or Gel-filtered Platelets
- Reduce blood draw by testing with 250uL micro-volume samples
Measuring ATP Release
- Quantitative analysis of Dense Granule Release
- Secretion Study and Aggregation performed simultaneously in same sample
- Diagnose Storage Pool Disease and Secretion Defects
- Fastest turn-around time and less labor-intensive compared to other methods
Ristocetin CoFactor Assay
- One Stop Shopping: Optical Aggregometer, Control Software, CoFactor Kit and Controls
- Create a Standard from three (3) to six (6) points
- Calculations include: Coefficient of Determination, Slope and CoFactor Activity
- CoFactor Activity calculated down to 3% [Type 3 Von Willebrand Disease]
For Intellectual Property - click here.
EC Rep.
Bio Top Medical, Poortgebouw Noord, Rijnsburgerweg 10, 2333 AA Leiden, Netherlands
UKRP
Obelis UK Ltd., Sanford Gate, East Point Business Park, Oxford, OX4 6LB, UK
US FDA
CHRONO-LOG Aggregation Systems and Reagents are FDA cleared.
